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Abstract
Rationale
The lower airway microbiota is important in normal immunological development and chronic
lung diseases (CLDs). Young children cannot expectorate and because of the uncertainty
whether upper airway samples reflect the lower airway microbiota, there have been few lon-
gitudinal paediatric studies to date.
Objectives
To assess whether throat swabs (TS) and cough swabs (CS) are representative of the lower
airway microbiota.
Methods
TS, CS, bronchoalveolar lavage and bronchial brushings were prospectively collected from
49 children undergoing fibreoptic bronchoscopy for CLDs. Bacterial DNA was extracted and
the 16S rRNA gene V4 region sequenced using the Illumina MiSeq.
Results
5.97 million high quality reads were obtained from 168 samples (47 TS, 37 CS, 42 BALF
and 42 bronchial brushings). CS sequenced poorly. At a community level, no difference in
alpha diversity (richness, evenness or Shannon Diversity Index) was seen between lower
airway samples and TS (P > 0.05). Less than 6.31% of beta diversity variation related to
sampling method for TS (P = 0.001). Variation between pathologies and individual patients
was greater (20%, 54% respectively P 0.001) than between TS and lower airway sam-
ples. There was strong correlation in the relative abundance of genera between samples
(r = 0.78, P < 0.001). Similarity between upper and lower airway samples was observed to
be less for individuals where one sample type was dominated by a single organism.
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Conclusions
At the community structure level, TS correlate with lower airway samples and distinguish
between different CLDs. TS may be a useful sample for the study of the differences in longi-
tudinal changes in the respiratory microbiota between different CLDs. Differences are too
great however for TS to be used for clinical decision making.
Introduction
Complex microbial communities inhabit the healthy lower airways, that were once thought to
be sterile, and are important in chronic lung diseases such as cystic fibrosis (CF)[1]. Using
molecular techniques, chronic suppurative airway diseases are now believed to be more poly-
microbial than previously appreciated[2–4] with increasing interest in the role the microbiota
has to play in shaping normal and pathological airway immune responses.
Whilst studies in adults have highlighted the importance of the microbiota in disease
progression in CF, comparatively less is known about the early development of the airway
microbiota in children. This is in part because longitudinal study of the airway microbiota in
children is challenging due to the difficulties in obtaining repeated lower airway samples. Most
children cannot spontaneously expectorate and obtaining bronchoalveolar lavage fluid (BALF)
frequently is neither ethical nor feasible. In the only two longitudinal studies of the infant
lower airway microbiota reported to date, BALF was collected infrequently (at most every 6
months)[5,6] thus limiting the utility of BALF to track concurrent changes in the microbiota
with symptoms. Nasopharyngeal sampling has also been used to track monthly changes in
the airway microbiota in infants[7–9], but this has been shown to be a poor surrogate for the
lower airway microbiota[10]. Thus, there is a need to identify a reliable surrogate for lower air-
way sampling which can be collected frequently and is well tolerated by children.
In clinical practice, cultures of either throat swabs (TS) or cough swabs (CS) are regularly
used as surrogates for lower airway samples. Culture dependent results of TS and CS are how-
ever unreliable due to variability in sensitivity when compared with lower airway results: e.g.
conventional culture sensitivity for Pseudomonas aeruginosa ranges from 35.7–71%[11,12].
Whether the poor sensitivity of upper airway samples is due to the limitations of microbial cul-
tures or the sampling method however remains unclear.
Similarities in the microbiota between throat swabs and lower airway samples have been
reported in older expectorating children with CF (TS compared with sputum)[10] as well as
in adults (N = 6 adults, TS compared with BALF)[13]. In younger children and infants with
chronic lung diseases, the use of upper airway samples, particularly CS, has not been validated
and was the objective of the present study. We hypothesised that upper airway samples (CS
and TS) would be a reliable surrogate for the lower airway microbiota. We aimed to compare
TS and CS with lower airway samples obtained at bronchoscopy in children with CLDs under-
going a clinically indicated procedure.
Methods
For additional details please see S1 Appendix.
Subjects and sampling
Children undergoing a clinical bronchoscopy at the Royal Brompton Hospital (RBH) between
December 2012 and May 2013 were recruited. Ethical approval was granted by the RBH NIHR
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the NIHR Respiratory Disease Biomedical
Research Unit at the Royal Brompton and Harefield
NHS Foundation Trust and Imperial College
London. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Biomedical Research Unit Advanced Lung Disease Biobank (NRES reference 10/H0504/9).
Parental written consent and age-appropriate assent from the child was obtained.
At least one upper airway (TS or CS) and a paired lower airway sample (BALF or bronchial
brushing) were collected from each child (see S1 Appendix). Bacterial culture of BALF was
performed as per standard clinical practice.
16S rRNA gene library preparation and sequencing
A maximum of 2 x 2ml aliquots of BALF (median 3.2ml, range 0.5–4ml) were centrifuged
at 21,000g for 30 minutes and the cell pellet retained for DNA extraction. Frozen swab and
brushing heads were transferred directly into a Lysing Matrix E tube containing sodium phos-
phate buffer. DNA was extracted using the MP Bio FastDNA Spin Kit for Soil (http://www.
mpbio.com) according to the manufacturer’s instructions.
Quadruplicate PCRs of the 16S rRNA gene V4 region were performed using a custom
indexed forward primer S-D-Bact-0564-a-S-15 (5’ AYT GGG YDT AAA GNG 3’), reverse
primer S-D-Bact-0785-b-A-18 (5’ TAC NVG GGT ATC TAA TCC 3’)[14] and a high fidelity
Taq polymerase master mix (Q5, New England Biolabs). A mock community was included to
assess sequencing quality. PCR cycling conditions were: annealing at 95˚C for 2 minutes fol-
lowed by 35 cycles at 95˚C for 20 seconds, 50˚C for 20 seconds and 72˚C for 5 minutes. Ampli-
cons were purified, quantified and equi-molar pooled to form a DNA library for paired-end
sequencing using the Illumina MiSeq V2 reagent kit [15] (S1 Fig for laboratory workflow).
With the exception of 10 samples (details given in S1 Appendix), all samples from an individ-
ual patient were run on the same plate to limit the impact of any batch effect.
Data analysis
Sample size was opportunistic in the absence of data to inform a power calculation at the
inception of the study. Upstream processing was performed using Quantitative Insights into
Microbial Ecology (QIIME) Version 1.9.0 (see S1 Appendix). Downstream analyses, to assess
community level differences in diversity and Operational Taxonomic Unit (OTU) level differ-
ences, were performed using Phyloseq in R version 3.2.0 (S2 Fig). Within samples, alpha-diver-
sity differences in richness (the number of different species), evenness (the spread of species)
and the Shannon Diversity Index were calculated using paired t-tests and Wilcoxon sign-
ranked tests for parametric and non-parametric data respectively. The Shannon Diversity
Index is a composite measure of richness and evenness which quantifies the uncertainty in
predicting species identity when randomly sampling from a community. Bland-Altman plots
were constructed to analyse the agreement in alpha diversity between samples.
Between sample, beta-diversity differences were tested using the Bray Curtis dissimilarity,
the unweighted UniFrac and weighted UniFrac scores using a permutational multivariate
ANOVA (PERMANOVA)[16], in which the r2 value represents the degree of variance in com-
munity composition explained by the variables tested in the model. Block designs were used
for paired comparisons between samples from the same patient. The Bray-Curtis index mea-
sures dissimilarity between two samples by estimating the number of shared organisms from
the total number of organisms present in both samples; the higher the Bray Curtis dissimilarity
score, the greater the difference between two samples. The UniFrac score is a qualitative mea-
sure of the phylogenetic distance between two communities, with the weighted UniFrac score
additionally accounting for the relative abundance of organisms within these samples. Quanti-
tative measures of beta diversity, such as Bray Curtis dissimilarity and weighted UniFrac
scores, provide information on community differences due to the relative abundance of
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species. The UniFrac score provides information on community differences driven by selective
pressures on the community[17].
OTU level differences were assessed using Spearman’s rank correlation. The Multtest pack-
age in R was used to perform multiple t-tests with Benjamini-Hochberg correction to compare
differences in the relative abundance of genera between upper and lower airway samples. A P
value of less than 0.05 was considered to be statistically significant. Sequence data is available
at the European Nucleotide Archive (Accession number: PRJEB14074).
Results
Patient demographics & sampling
Patient characteristics are detailed in Table 1. In total 47 TS, 37 CS, 42 BALF samples and 42
bronchial brushings were collected, with 23 of the 49 patients providing all sample types and a
median of 3 samples collected per patient. Reasons for missed samples included: infants who
were too young to perform a CS (n = 12); children who were unable to tolerate TS sampling
due to gagging and vomiting (n = 2); lack of parental consent for bronchial brushings (n = 7),
and insufficient BALF remaining for research after aliquoting for clinical purposes (n = 7). For
the remaining 26 patients, at least one pair of upper and lower airway samples was collected
Table 1. Summary of patient characteristics (n = 49) in the comparison of the upper and lower airway microbiota.
CSLD—chronic suppurative lung disease; CF—cystic fibrosis; NBS—newborn screened; PCD—Primary ciliary
dyskinesia.
Demographic Median (range) or n (%)
Age (years) 5.4 (0.1–16.2)
Gender (female) 29 (59)
Underlying pathology
• CF (Newborn screened [NBS] infants) • 12 (25)
• CF (not NBS) • 5 (10)
• PCD • 5 (10)
• Recurrent LRTI • 24 (49)
• Upper airway pathology • 2 (4)
• Haemoptysis • 1 (2)
Current symptoms
• Lower respiratory • 10 (20)
• Upper respiratory • 21 (42)
Antibiotic usage
Current treatment course 14 (29)
• Intravenous (IV) • 3 (6)
• Oral • 8 (16)
• Nebulised • 6 (12)
Oral prophylaxis 20 (41)
• Augmentin • 2 (4)
• Azithromycin • 9 (18)
• Flucloxacillin • 9 (18)
Inhaled corticosteroids 12 (25)
Bronchoscopy route
• Oral (Via laryngeal mask airway) • 11 (22)
• Nasal • 38 (78)
https://doi.org/10.1371/journal.pone.0201156.t001
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thereby allowing comparisons to be made (Fig 1). Twenty-six of the 42 BALFs obtained were
culture positive.
Indications for bronchoscopy included: chronic suppurative lung disease (CSLD—namely
CF and Primary Ciliary Dyskinesia [PCD]) (45%) diagnosed on standard criteria[18], [19],
and non-CSLD controls (55%). The majority of the controls (24/27, 89%) were being investi-
gated for recurrent lower respiratory tract infections (LRTI). For those with CSLD, twenty
(25%) were infants with CF diagnosed on newborn screening (NBS) undergoing a routine
bronchoscopy at 3–5 months of age[20]. The age distribution of patients was skewed with a
median of 5.4 years (0.1–16.2 years). Thirty-nine patients (80%) were clinically stable at the
Fig 1. Illustration of the combinations of upper and lower airway samples taken. Forty-nine patients were recruited and in forty-
seven patients, a throat swab and at least 1 lower airway sample was obtained for comparison. Samples for forty-two patients
remained after rarefying to 1000 reads: 8 patients remained in whom all 4 samples were available; 39 had TS and at least a paired
lower airway sample (either BALF, bronchial brushing or both), and 17 had CS and a paired lower airway sample. n—number of
subjects. After rarefaction, some subjects had fewer samples for comparison and therefore moved into a different category.
https://doi.org/10.1371/journal.pone.0201156.g001
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time of bronchoscopy. Eighteen patients (37%) had received a treatment course of antibiotics
in the previous 30 days, with 29% receiving antibiotics at the time of bronchoscopy (either
intravenous [IV], oral, nebulised or a combination).
Sequencing
16S rRNA gene sequencing was performed on 168 extracted DNA samples. After initial pro-
cessing and quality control, a total of 5.97 million reads were obtained with an average of
31,117 reads per sample (range 118–192,812 reads). Technical and PCR negative controls were
examined to identify potential contaminant OTUs. Three individual OTUs were found to be
highly abundant in technical and PCR control samples and were removed: Burkholderia (OTU
ID 1606), Undibacterium (OTU ID 1727) and Ralstonia (OTU ID 1703). In addition, the gen-
era Bradyrhizobium spp., Sediminibacterium spp. and Methylobacterium spp. were removed as
these have previously been identified as common reagent contaminants[21]. A small signifi-
cant batch effect was found between the two sequencing runs using Bray Curtis dissimilarity
(r2 = 0.03, P = 0.001) and unweighted UniFrac scores (r2 = 0.01, P = 0.03), but not the weighted
UniFrac score (r2 = 0.01, P = 0.69).
Prior to downstream processing, data was filtered to remove OTUs with less than 20 total
reads. Samples were rarefied to 1,000 reads and any sample with fewer than 1,000 reads
removed (rationale for rarefaction level chosen detailed in the S1 Appendix and S3 Fig). After
rarefaction 34/42 (81%) of the BALFs, 36/42 (86%) bronchial brushings, 44/47 (94%) TS and
17/37 (46%) CS remained. CS sequenced poorly, mostly likely due to having a very low bio-
mass, and consequently post rarefaction only 8 patients remained in whom all 4 samples (TS,
CS, BALF and bronchial brushing) were available for comparison. In contrast, post rarefaction
39 patients had a TS and at least a paired lower airway sample remaining with 17 having a CS
and paired lower airway sample (Fig 1).
Comparison of the upper and lower airway microbiota
For BALF and bronchial brushings, the three most common genera were identical: Haemophi-
lus spp. (23.6% and 24.6% of total reads respectively), Streptococcus spp. (20.3% and 20.5%)
and Prevotella spp. (6.5% and 7.9%). Similar genera were seen in TS but with Streptococcus spp.
the most common (39.5%) followed by Haemophilus spp. (15.4%) and Prevotella spp. (8.7%).
At an OTU level, there was no difference observed between upper and lower airway samples
(Fig 2).
Comparing alpha diversity between paired BALF and bronchial brushings (N = 26), no sig-
nificant differences were found in richness (median for BALF = 57.5 (range 12–87), for bron-
chial brushings = 50, (range 14–101), P = 0.578), evenness (median for BALF = 0.60 [range
0.16–0.75], for bronchial brushings = 0.55 [range 0.13–0.70] P = 0.084), or by the Shannon
Diversity Index (median for BALF 2.46 [range 0.39–3.22], for bronchial brushings 2.18 [range
0.37–3.19], P = 0.173). Similarly no differences were observed for beta diversity (Bray Curtis
dissimilarity index [P = 0.650, r2 = 0.005], unweighted UniFrac score [P = 0.114, r2 = 0.02],
weighted UniFrac score [P = 0.255, r2 = 0.008]). Consequently where both BALF and bronchial
brushings were available for comparison with TS, bronchial brushings were used.
Looking at individual patient barplots the airway microbiota was revealed to be highly indi-
vidual (S4 Fig), with some similarities observed between TS and lower airway samples (Fig 3).
Streptococcus spp., however, appears to be more abundant in TS compared to lower airway
samples. Communities with low evenness were in most cases dominated by a single organism.
There was a trend for the dominant organism in the lower airway sample to be the same bacte-
rium isolated by routine clinical culture of BALF (S1 Appendix and S4 Fig).
Comparison of the upper and lower airway microbiota in children
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Comparing TS and either BALF or bronchial brushings (N = 39), no significant difference
was found in richness (median for lower airway samples = 51 [range 14–101], for TS = 47
[range 25–70], P = 0.120), evenness (median for lower airway samples = 0.55 [range 0.13–0.76],
for TS = 0.56 [range 0.09–0.75], P = 0.809) or by the Shannon Diversity Index (median for lower
airway samples = 2.18 [range 0.37–3.29], for TS = 2.13 [range 0.31–3.17], P = 0.777, Fig 4).
For those individuals showing a difference in alpha diversity between upper and lower air-
way samples, Bland-Altman plots of alpha diversity measurements revealed somewhat less
agreement between TS and lower airway samples with low evenness (S5 Fig). This again sug-
gests that there is less concurrence between TS and lower airway samples in the presence of a
dominant organism. The mean Shannon Diversity Index was 2.09 (standard deviation [SD
0.64] for TS and 2.12 [SD 0.78] for lower airway samples). A small significant difference
(P = 0.001) was found in beta-diversity between TS and lower airway samples using the Bray
Curtis, unweighted and weighted UniFrac scores (r2 = 0.06, 0.03 and 0.06 respectively [Fig 5]).
Considering genera, 80% (72 out of 90) were in common between lower airway samples
and TS, whilst 15.6% (14 out of 90) were unique to BALF and 4.4% (4 out of 90) were unique
Fig 2. Heatmap showing similarities in the relative abundances of the top 50 OTUs present between upper (throat swabs [TS] and cough swabs [CS]
and lower airway samples (bronchoalveolar lavage fluid [BALF] and bronchial brushings).
https://doi.org/10.1371/journal.pone.0201156.g002
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to TS. None of the genera unique to BALF were grown on bacterial culture of the same sample.
The few genera different between upper and lower airway samples were present in very low
relative abundance (< 0.1%).
Spearman’s rank correlation testing showed good correlation between the relative abun-
dances of genera and OTUs present when comparing lower airway samples with TS (genera
level: r = 0.776, P< 0.001; OTU level: r = 0.557, P< 0.001). Using multiple paired t-tests with
Benjamini-Hochberg correction to compare the relative abundance of genera, a significantly
higher relative abundance of Streptococcus spp. was seen (t = -182, P< 0.0001, Padj = 0.0009)
for TS. No other genus was significantly different between TS and lower airway samples
(Padj > 0.05) (Table 2).
Although CS sequenced poorly, when successfully sequenced they showed similarities in
diversity with lower airway samples (see S1 Appendix).
Clinical variables influencing correlation between the upper and lower
airway microbiota
To determine whether specific clinical features underpinned the differences in similarly
between upper and lower airway samples (Fig 3), beta-diversity testing was performed using a
Fig 3. Individual patient barplots (N = 39) comparing paired lower airway samples and TS for the 50 most common OTUs. The relative abundance
of OTUs for each sample is shown with TS below and their corresponding lower airway sample above. Bars are of uneven heights due to the presence of
low abundance “other” OTUs which have not been included in the plot. This illustrates that the airway microbiota is highly individual with variable
degrees of similarity between TS and lower airway samples.
https://doi.org/10.1371/journal.pone.0201156.g003
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PERMANOVA including a total of 11 variables—those listed in Table 1 as well as “Patient ID”
(i.e. which patient was sampled) and “Sample type”. The influence of FOB route and underly-
ing pathology were tested in separate PERMANOVAs using FOB samples or TS only respec-
tively. Two variables were found to exert a large influence on community structure. “Patient
ID” had the largest influence accounting for 47.0–53.8% of the variance (for the unweighted
UniFrac and Bray Curtis dissimilarity scores respectively, P = 0.001), whilst the underlying
pathology accounted for 18.7%– 22.5% (unweighted UniFrac and Bray Curtis dissimilarity
scores respectively, P 0.006) (Table 3). FOB route accounted for 5.43%–8.16% of the vari-
ance (unweighted and weighted UniFrac respectively, P< 0.05), with fewer Corynebacterium
spp. (OTU 2657), Moraxella spp. (OTU 1365) and Dolosingranulum spp. (OTU 349) present
in FOB performed nasally as opposed to FOB through the oral route. Other significant vari-
ables, but similarly of more minor influence, included the use of prophylactic antibiotics and
nebulized antibiotics. Patient age was not a significant influence on community structure.
Discussion
In summary, the present study has revealed that TS sequence well (94% of samples sequenced)
in contrast to CS that sequenced poorly (44%). We attribute this to the limited biomass and
recoverable microbial DNA for CS and the use of CS as a sample for sequencing is therefore
not recommended.
Fig 4. Alpha-diversity comparisons between lower airway samples and throat swabs. No significant difference was seen in: (a)
richness (t(38) = 1.6523, P = 0.107); (b) evenness (W(38) = 367, P = 0.756), and (c) Shannon diversity index (W(36) = 384, P = 0.940).
https://doi.org/10.1371/journal.pone.0201156.g004
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When comparing TS with lower airway samples (either BALF or bronchial brushings), a
strong correlation was seen in the relative abundance of genera and there was no significant
difference in within sample alpha diversity. Whilst a significant difference in beta diversity was
seen between sample types, the degree of variation due to sample site and other clinical vari-
ables, such as antibiotic usage, was small. This was consistent when testing whether similar
organisms were present between samples (Bray Curtis dissimilarity) and when testing the rela-
tive abundance and phylogenetic relationships between samples (UniFrac and weighted Uni-
Frac scores).
There was greater variability between disease states (up to 22.5%) than between upper and
lower airway samples. However, the number of children with discordant lower and upper air-
way samples precludes the use of TS for clinical decision making in individuals. Nevertheless
TS contain valuable research information that could be used to explore the development of the
lower airway microbiota in groups of children with different diseases. For example, TS could
be used to determine whether the more benign clinical course of PCD compared to that of CF
relates to different temporal evolution of the lower airway microbiota.
Discordant dominance of an OTU in either the upper or lower airway sample led to greater
dissimilarity between TS and lower airway samples. For those samples showing the greatest
dissimilarity, there was a trend for the dominant organism in BALF to be the same organism
grown on bacterial cultures of the same fluid. This could suggest overgrowth of an organism
in an individual sample, or low biomass in that sample allowing artificial dominance of an
Fig 5. Non-metric multidimensional scaling (NMDS) plot comparing the UniFrac score between patients. This shows similarity
in the clustering pattern between lower airway samples and throat swabs.
https://doi.org/10.1371/journal.pone.0201156.g005
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organism. Quantitative PCR was not performed as part of this study and may have helped
determine whether low biomass contributed to this observation. Therefore, where samples are
dominated by an individual genus, the results should be treated with caution and repeat upper
airway sampling paired with culture dependent microbiology is wise. Upper airway samples
may therefore fail to detect dominant pathogens in the lower airways and vice versa, limiting
clinical use in an individual child but also a consideration for the design of research studies.
Two main factors influenced the degree of variation in the airway microbiota. The patient
sampled had the greatest influence (53.8% of variation, Bray Curtis dissimilarity score). This
confirms that the microbiota is individual to a patient[22–24]. The underlying pathology
accounted for up to 22.5% of variation in TS, suggesting TS detect disease differences
Table 2. Comparing the mean relative abundance (percent) of the most common or clinically important genera
between TS and paired lower airway samples (BALF or bronchial brushing). Using multiple paired t-tests with Ben-
jamini-Hochberg correction, only Streptococcus spp. was significantly different (P(adj) = 0.0009). TS—throat swab; NS
—non-significant (P(adj) > 0.05). SD—standard deviation.
Genus Lower airway mean
(SD)
TS mean
(SD)
P(adj)-value
Haemophilus spp. 25.2 (24.4) 15.6 (16.2) 0.35
Streptococcus spp. 21.5 (22.2) 39.7 (22.8) 0.0009
Prevotella spp. 7.7 (9.9) 8.3 (10.0) 0.89
Neisseria spp. 6.9 (10.1) 4.6 (6.3) 0.47
Moraxella spp. 6.2 (17.4) 1.4 (7.0) 0.47
Veillonella spp. 4.2 (5.6) 6.8 (7.1) 0.35
Staphylococcus spp. 4.1 (16.3) 0.2 (0.7) 0.47
Gemella spp. 3.0 (2.6) 5.3 (7.3) 0.42
Fusobacterium spp. 2.6 (3.8) 1.3 (2.0) 0.42
Serratia spp. 2.6 (15.9) 0.05 (0.1) 0.55
Corynebacterium spp. 2.2 (6.6) 0.03 (0.1) 0.35
Granulicatella spp. 1.7 (1.7) 4.2 (3.9) 0.05
Dolosingranulum spp. 1.6 (4.2) 0.03 (0.1) 0.35
Porphyromonas spp. 1.6 (5.4) 1.2 (2.5) 0.79
Leptotrichia spp. 1.1 (2.7) 1.0 (2.6) 0.83
Rothia spp. 0.5 (1.0) 4.5 (15.6) 0.42
Burkholderia spp. 0.1 (0.1) 0.00 (0.02) 0.35
Pseudomonas spp. 0.04 (0.1) 0.04 (0.1) 0.90
Ralstonia spp. 0.04 (0.1) 0.01 (0.03) 0.42
https://doi.org/10.1371/journal.pone.0201156.t002
Table 3. Beta diversity summaries of significant clinical variables influencing community structure. Adonis (PER-
MANOVA) results shown are for those variables which were statistically significant (P< 0.05) using the Bray Curtis
dissimilarity score. IV—intravenous. FOB—fibreoptic bronchoscopy.
Variable & diversity measurement r2 P-value
Sample Type 0.06 0.001
Patient ID 0.54 0.001
Underlying pathology 0.20 0.001
Lower respiratory tract symptoms 0.02 0.003
Nebulised antibiotics 0.02 0.003
Current IV antibiotics 0.01 0.012
FOB route 0.08 0.001
https://doi.org/10.1371/journal.pone.0201156.t003
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which may be useful in longitudinal studies of the airway microbiota when comparing differ-
ent patient groups.
Our findings in 49 children are similar to those of Charlson et al.[13], who demonstrated
similarity of the microbiota along the respiratory tree in 6 adults (including smokers), and
Boutin et al.[10] who demonstrated similarities between TS and sputum samples in 20 adults
and children with CF with a mean age of 16.1 years. Similarly, Marsh et al.[25] compared
upper airway samples (nasopharyngeal and oropharyngeal swabs) with BALF sampled from a
single lobe and found upper airway samples were a reliable surrogate in 69% of children with
either idiopathic bronchiectasis, protracted bacterial bronchitis or healthy airways. Our cur-
rent study we believe is the first to compare the microbiota using both TS and CS and lower
airways samples in young children with CSLD (CF or PCD) and non-CSLD controls (mainly
recurrent LRTI), which is representative of the pathologies frequently encountered in Paediat-
ric Respiratory Medicine. This is important since children are less able to spontaneously
expectorate and in whom finding a reliable surrogate for lower airway sampling which can be
obtained frequently is particularly pertinent.
Our study may be underpowered as we were unable to perform an a priori power calcula-
tion (S1 Appendix). A significant difference in beta-diversity was however observed meaning
differences between groups of patient samples could be detected. Nonetheless caution should
be taken in relation to the interpretation of the CS data given the low sample size (N = 17) and
their very low biomass, rendering them at increased risk of contamination by spurious OTUs.
Low biomass also will have contributed to the variation in sequencing depth between samples
and the need to rarefy to a level balancing capturing OTUs and retaining sufficient samples for
paired comparisons. However, higher sequencing depths do not lead to improved identifica-
tion of ecological patterns[26].
Eighteen patients (37%) had received a course of antibiotics in the previous 30 days and
41% were prescribed prophylactic antibiotics. Whilst this could potentially introduce a bias
in our results by influencing both the upper and lower airway microbiota so that they show
greater similarity, it would not have been ethically permissible to stop a clinically indicated
treatment for the purposes of this study, and indeed many of these patients are prescribed anti-
biotics in routine clinical practice. Nonetheless, we accept that extrapolation of our results to
antibiotic-naïve children should be cautious.
Ideally, all bronchoscopies would have been performed either via an LMA or endotracheal
tube in order to minimize risk of contamination of the bronchoscope. The route was deter-
mined by clinical considerations. Bronchoscopy route accounted for up to 8.16% variance in
community structure, much less than the variance due to the individual patient (53.8%) or the
underlying disease (22.5%). Greater abundance of organisms associated with the nasal passages
such as Corynebacterium was seen in samples where bronchoscopy was performed transna-
sally. Similarly, contamination of upper airway samples with the oral microbiota cannot be
excluded, although care was taken to limit for this by avoiding contact with the oral cavity dur-
ing sampling and not using suction until the bronchoscope was below the vocal cords. Naso-
pharyngeal samples were not collected and have previously been found to be highly diverse in
young children[27].
BALF was only collected and pooled from two lung lobes in this study. As lobar differences
exist in bacterial distribution[28], ideally all six lobes would have been sampled to determine
geographical consistency More work is needed on intra-lobar differences and the relationship
with upper airway cultures.
A small significant batch effect was seen between sample plates using the Bray Curtis and
weighted UniFrac scores (r2 = 3.32% and 3.82% respectively). Except for 10 samples, all
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samples from an individual patient were however, run on the same plate thereby limiting the
impact of any batch effect.
In summary, CS sequenced poorly and their use cannot be recommended for non-culture
based microbiota studies. Considering TS as a surrogate for lower airway samples, although
representative at a community level and at this level can demonstrate disease differences,
throat swabs can show substantial differences at the individual patient level. Notably larger
differences are observed when samples are dominated by an individual organism, the latter
being identified by both molecular and culture-dependent techniques. A combination of
these two techniques may be an important consideration and advantageous in order to
obtain a comprehensive assessment of a patient’s airway bacterial community. Consequently
TS do not have utility for individual clinical decision making but they provide an opportu-
nity as a research tool for tracking longitudinal changes in groups of patients with, for exam-
ple, CF and PCD.
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S1 Appendix. Supplementary methods and results for the comparison of the upper and
lower airway microbiota in children with chronic lung diseases.
(DOCX)
S1 Fig. Illustration of the methodological steps in sample processing from DNA extraction
to 16S rRNA gene sequencing using the Illumina MiSeq.
(TIF)
S2 Fig. Diagram illustrating the analysis pipeline for sequences obtained from the Illumina
MiSeq. Upstream analyses were performed in QIIME and downstream analyses were per-
formed in Phyloseq in R.
(TIF)
S3 Fig. Rarefaction curves with yellow lines denoting the number of OTUs sampled at
1,000 reads and 3,000 reads. This illustrates that an asymptote is reached by 1,000 reads. At
this threshold, the majority of OTUs have been sampled and little additional information is
obtained at higher rarefaction levels. Consequently a rarefaction level of 1,000 reads was cho-
sen.
(TIF)
S4 Fig. Illustrating individual patient barplots (N = 40) organised from those showing the
greatest similarity between upper and lower airway samples to those showing the least sim-
ilarity (determined by Bray Curtis dissimilarity). Only BALF samples were sent for bacterial
culture as part of routine clinical care. The results of BALF culture and disease group are also
detailed.
(PDF)
S5 Fig. Bland Altman plots showing agreement between TS and lower airway samples in
alpha diversity measurements illustrated by (a) richness, (b) evenness and (c) Shannon
Diversity Index. Overall agreement is seen between samples, apart from at low levels of even-
ness and Shannon Diversity.
(TIF)
S1 Table. Summary of sequencing quality statistics.
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